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Sir,
Vitiligo is a disease caused by loss of melanocytes. It can 
be classified as segmental, acrofacial, generalized and 
universal, or by pattern of involvement, such as focal, 
mixed, and mucosal types. In generalized and universal 
vitiligo, the entire body surface may be depigmented, 
leaving only a few normally pigmented macules and pat-
ches in some areas (1). Therefore it is sometimes difficult 
to diagnose generalized vitiligo if the patient does not 
show any normally pigmented macules. We report here 
a rare case of repigmentation after strong sun exposure 
in a patient diagnosed with vitiligo universalis.
CASE REPORT
A 63-year-old man, known to have generalized vitiligo 
of 40 years’ duration, presented with newly developed 
multiple brown to black macules on both the perior-
bital areas and cheeks (Fig. 1a). Pigmentary lesions 
had developed after exposure to strong sun 3 months 
previously. He had not received any treatment, such as 
phototherapy, systemic or topical steroids and immu-
nosuppressants, for over 30 years. Initially, pigmentary 
disease was suspected, with the differential diagnosis 
including freckles, lentigines and melasma. A skin 
biopsy performed on the cheek showed increased basal 
melanin pigmentation (Fig. 2). In combination with 
the histopathological results and medical history, the 
hyperpigmented lesions were diagnosed as the patient’s 
normal skin with increased melanin deposition in the 
basal layer due to activation of residual melanocytes. 
Since the patient did not want to treat the vitiligo lesion 
himself, we treated the hyperpigmented lesion with a 
Nd:YAG (532 nm) laser. The hyperpigmented lesions 
cleared after two treatments with the laser (Fig. 1b). 
DISCUSSION
Although several theories have been proposed to explain 
the loss of functioning melanocytes in vitiligo, the pre-
cise cause remains unknown. Theories include the pre-
sence of autoantibodies against various tissues, cytotoxic 
T cells, oxidative stress, neural and viral mechanisms 
(2). Most of the published studies report the complete 
absence of melanocytes in depigmented vitiliginous 
skin, suggesting that only hair follicles act as a reservoir. 
However, several reports suggest that vitiligo lesions are 
not totally devoid of melanocytes (3–5). A study by Tobin 
et al. (5) provides evidence that melanocytes are never 
completely absent in the depigmented epidermis and that 
these melanocytes can recover their functionality under 
an appropriate stimulus. It is possible that sun exposure 
was responsible for initiating melanocyte activity in the 
depigmented skin of our patient. 
In patients with extensive vitiligo, depigmentation 
therapy is often preferred over attempts to restore skin 
colour. Monobenzone or monobenzyl ether of hydroqui-
none is used routinely for depigmentation of normally 
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Fig. 1. (a) Multiple brown to black 
macules on periorbital areas and 
cheeks. (b) Complete depigmentation 
after 2 sessions of Nd:YAG (532 nm) 
laser treatment.
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pigmented macule and patches in patients with universal 
vitiligo (6). Q-switched ruby laser (694 nm), alexan-
drite laser (755 nm) and cryotherapy are shown to be 
highly effective in selectively targeting melanocytes for 
destruction, thus causing depigmentation (7–9). In our 
case, Nd:YAG (532 nm) laser was effective in removing 
repigmented lesion in patients with universal vitiligo. 
Pigmentary spots appearing in a patient with vitiligo 
universalis may be misdiagnosed as pigmentary disease 
rather than vitiligo. To avoid misdiagnosis, physicians 
must evaluate the hyperpigmented macule with care.
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Fig. 2. A skin biopsy, performed on 
the cheek, showed increased basal 
melanin pigmentation and solar 
elastosis (haematoxylin and eosin 
(H&E : a ×40; b ×100).
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